期刊文献+

四联重组痘苗病毒的构建及筛选 被引量:2

Construction and selection of recombinant vaccinia virus with four genes combined
原文传递
导出
摘要 构建含黄热病毒E基因、汉坦病毒S基因、克里米亚-刚果出血热病毒M基因及炭疽杆菌POAX2基因的重组天坛株痘苗病毒。设计合成含外源筛选标记EGFP基因和4种拟插入外源基因的重组质粒,利用同源重组和荧光标记筛选技术并结合Cre/Loxp敲除系统,最终构建四联重组痘苗病毒。应用PCR对获得的重组痘苗病毒进行鉴定和遗传稳定性的检测,并在电子显微镜下观察其形态特征。构建含4种外源基因的重组痘苗病毒rVTT-C-4+,该重组痘苗病毒在转录水平上具有良好的遗传稳定性,且于电镜下观察具备完整形态。成功构建四联重组天坛株痘苗病毒,为后续疫苗研究奠定了基础。 To construct a recombinant vaccinia virus contained Yellow fever virus envelope protein E gene, Hantaan virus S gene,Crimean-Congo hemorrhagic fever virus M gene and the POAX2 gene of Bacillus anthracis strain. We designed and synthesized a recombinant plasmid including four exogenous genes and EGFP gene, using homologous recombination combined with Cre/Loxp system to get recombinant vaccinia virus. Then,we used PCR to identify and detect genetic stabili- ty of the recombinant virus. At the same time, we observed the morphological characteristics of the recombinant virus by electron microscope observation. We got a recombinant vaccinia virus contained four exogenous genes. The recombinant vaccinia virus has a good genetic stability on transcription,and complete morphology. We successfully constructed the recombinant vaccinia vi- rus with four exogenous genes inserted and laid the foundation for subsequent research.
出处 《中国兽医学报》 CAS CSCD 北大核心 2014年第9期1411-1415,1417,共6页 Chinese Journal of Veterinary Science
基金 吉林省重点科技攻关资助项目(20130206041NY)
关键词 天坛株痘苗病毒 多联疫苗 EGFP Cre/Loxp敲除系统 vaccinia virus Tian Tan strain combination vaccines EGFP Cre/Loxp system
  • 相关文献

参考文献18

二级参考文献132

  • 1吴壮,徐军.Cre/Loxp位点重组酶系统在疾病动物模型建立中的应用[J].国外医学(呼吸系统分册),2004,24(4):254-256. 被引量:4
  • 2娄元梅,阮力,朱既明.痘苗病毒毒力相关基因的研究进展[J].病毒学报,1996,12(1):88-96. 被引量:2
  • 3Theiler M,Smith H H.The use of yellow fever virus modified 45 by in vitro cultivation for human immunization[J].Exp Med,1937,65:787-800.
  • 4Bharati K,Vruti S.Japanese encephalitis:development of new candidate vaccines[J].Expert Rev Anti Infect Ther,2006,4:313-324.
  • 5Chu J H,Chiang C C,Ng M L.Immunization of flavivirus West Nile recombinant envelope domain Ⅲ protein induced specific immune response and protection against West Nile vires infection[J].Immunol,2007,178(5):2699-2705.
  • 6Wu S C,Yu C H,Lin CW,et al.The domain Ⅲ fragment of Japanese encephalitis virus envelope protein:mouse immunogenicity and liposome adjuvanticity[J].Vaccine,2003,21(19/20):2516-2522.
  • 7Mota J,Acosta M,Argotte R,et al.Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain Ⅲ of the envelope protein[J].Vaccine,2005,23 (26):3469-3476.
  • 8Chu J J H,Bajamanonmani R,Li J,et al.Inhibition of West Nile virus entry by using a recombinant domain Ⅲ from the envelope glycoprotein[J].Gen Virol,2005,86(Pt.2):405-412.
  • 9Shwn C C,Patrick S C L,Chun P L,et al.Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coil protects mice from virus challenge[J].Microbial Pathogenesis,2001,31:9-19.
  • 10Alka K B,Malik Y P S,Sndhaushu V.Immunogenlcity and protective efficacy of the E.coli-exprossed domain Ⅲ of Japanese encephalitis virus envelope protein in mice[J].Med Microbiol Immunol,2007,196:227-231.

共引文献33

同被引文献28

  • 1杨卉娟,廖国阳,李卫东.联合疫苗发展概况[J].国际生物制品学杂志,2006,29(2):66-69. 被引量:6
  • 2张馨月,张存,冉多良.鸭瘟病毒强弱毒株TK基因的克隆及序列比较分析[J].新疆农业大学学报,2007,30(4):29-33. 被引量:4
  • 3Ferrari M,Mettenleiter T C,Romanelli M G,et al.A comparative study of pseudorabies virus(PRV)strains with defects in thymidine kinase and glycoprotein genes,Journal of Comparative Pathology[J].2000,123(2-3):152-163.
  • 4Abrams C C,Dixon L K.Sequential deletion of genes from the African swine fever virus genome using the cre/lox P recombination system.Virology[J].2012 Nov 10;433(1):142-8.
  • 5Sambrook J,Fritsch E F,Maniatis T著.分子克隆实验指南(2版)[M].金冬雁,黎孟枫译.北京:科学出版社,1992.
  • 6Roush S W,Murphy T V.Historical comparisons of morbidity and mortality forvaccine preventable diseases in the United States[J].JAMA,2007,298:2155-2163.
  • 7Verheust C,Goossens M,Pauwels K,et al.Biosafety aspects of modified vaccinia virus Ankara(MVA)-based vectors used for gene therapy or vaccination[J].Vaccine,2012,30(16):2623-2632.
  • 8Viner K M,Girgis N,Kwak H,et al.B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals[J].Virology,2007,361(2):356-363.
  • 9Remy-Ziller C,Germain C,Spindler A,et al.Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16E1protein[J].Clin Vaccine Immunol,2014,21(2):147-155.
  • 10Noisumdaeng P,Pooruk P,Kongchanagul A,et al.Biological properties of H5hemagglutinin expressed by vaccinia virus vector and its immunological reactivity with human sera[J].Viral Immunol,2013,26(1):49-59.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部